Healthcare provider profile · identity verified

Isil Uzun Smith, MD

Internal Medicine · BOSTON, MA · NPI 1609305945

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	483	220
Amlodipine Besylate	Amlodipine Besylate	321	153
Lisinopril	Lisinopril	279	122
Losartan Potassium	Losartan Potassium	233	108
Rosuvastatin Calcium	Rosuvastatin Calcium	230	98
Levothyroxine Sodium	Levothyroxine Sodium	199	93
Metformin Hcl	Metformin Hcl	172	78
Albuterol Sulfate Hfa	Albuterol Sulfate	171	76
Omeprazole	Omeprazole	168	72
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	130	49
Gabapentin	Gabapentin	121	68
Pantoprazole Sodium	Pantoprazole Sodium	119	43
Hydrochlorothiazide	Hydrochlorothiazide	116	55
Doxycycline Monohydrate	Doxycycline Monohydrate	108	106
Trazodone Hcl	Trazodone Hcl	105	46
Alendronate Sodium	Alendronate Sodium	102	49
Glipizide	Glipizide	99	40
Meloxicam	Meloxicam	96	65
Metoprolol Tartrate	Metoprolol Tartrate	94	31
Jardiance	Empagliflozin	88	38
Potassium Chloride	Potassium Chloride	80	45
Simvastatin	Simvastatin	78	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	77	33
Furosemide	Furosemide	75	42
Ozempic	Semaglutide	75	17
Metformin Hcl Er	Metformin Hcl	73	34
Prednisone	Prednisone	73	66
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	71	68
Atenolol	Atenolol	69	30
Spironolactone	Spironolactone	67	26
Baclofen	Baclofen	62	36
Ibuprofen	Ibuprofen	58	37
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	58	30
Montelukast Sodium	Montelukast Sodium	54	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	53	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	52	49
Tamsulosin Hcl	Tamsulosin Hcl	50	30
Victoza 2-Pak	Liraglutide	48	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	22
Carvedilol	Carvedilol	45	21
Glipizide Er	Glipizide	43	22
Ondansetron Hcl	Ondansetron Hcl	43	13
Pradaxa	Dabigatran Etexilate Mesylate	42	20
Tramadol Hcl	Tramadol Hcl	42	18
Wixela Inhub	Fluticasone Propion/Salmeterol	40	20
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	38	38
Duloxetine Hcl	Duloxetine Hcl	38	18
Famotidine	Famotidine	37	20
Spiriva Respimat	Tiotropium Bromide	37	16
Sumatriptan Succinate	Sumatriptan Succinate	35	11
Bisoprolol Fumarate	Bisoprolol Fumarate	34	19
Hydralazine Hcl	Hydralazine Hcl	34	21
Triamcinolone Acetonide	Triamcinolone Acetonide	33	15
Allopurinol	Allopurinol	31	16
Fluoxetine Hcl	Fluoxetine Hcl	31	15
Humulin N	Insulin Nph Human Isophane	31	11
Lorazepam	Lorazepam	31	suppressed
Ciclopirox	Ciclopirox	30	25
Ondansetron Odt	Ondansetron	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	13
Mirtazapine	Mirtazapine	29	12
Eliquis	Apixaban	27	11
Ezetimibe	Ezetimibe	27	suppressed
Sertraline Hcl	Sertraline Hcl	26	12
Terazosin Hcl	Terazosin Hcl	26	13
Nortriptyline Hcl	Nortriptyline Hcl	25	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	24	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	18
Pregabalin	Pregabalin	24	suppressed
Cephalexin	Cephalexin	23	19
Humulin R	Insulin Regular, Human	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Lovastatin	Lovastatin	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	15
Hydroxyzine Hcl	Hydroxyzine Hcl	21	12
Nystatin	Nystatin	21	11
Ofloxacin	Ofloxacin	21	18
Finasteride	Finasteride	20	12
Ketoconazole	Ketoconazole	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Morphine Sulfate	Morphine Sulfate	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Fentanyl	Fentanyl	19	suppressed
Naproxen	Naproxen	19	14
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	19	19
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Azithromycin	Azithromycin	18	17
Chlorthalidone	Chlorthalidone	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Metoprolol Succinate	Metoprolol Succinate	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	17
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Fluconazole	Fluconazole	17	17
Hydrocortisone	Hydrocortisone	17	11
Metronidazole	Metronidazole	17	suppressed
Breyna	Budesonide/Formoterol Fumarate	16	12
Colchicine	Colchicine	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Lactulose	Lactulose	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Liraglutide	Liraglutide	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	15	suppressed
Cromolyn Sodium	Cromolyn Sodium	14	suppressed
Fluocinolone Acetonide Oil	Fluocinolone Acetonide Oil	14	suppressed
Humalog	Insulin Lispro	14	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Trospium Chloride	Trospium Chloride	14	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	12	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Estradiol	Estradiol	11	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error